手机版
Ky开元集团手机版
Ky开元集团小程序
官方微信
公众号：chem17
扫码关注视频号
资料简介
Virogen是一家专注于为全球科研与诊断市场提供高质量生物试剂的抗体公司。公司由哈佛大学和麻省理工学院（MIT）的科学家团队创立，依托顶尖学术资源，始终致力于推动生命科学领域的技术创新。
作为行业核心供应商，Virogen的核心产品线涵盖研究级抗体、高纯度抗原及专业实验室设备三大领域。公司定期扩充产品目录，通过严格的质量控制体系确保试剂在免疫印迹（WB）、免疫组化（IHC）、流式细胞术（Flow Cytometry）等关键应用中表现稳定可靠。其特色服务包括定制化抗体/抗原开发和合同研究服务（CRO），可针对客户特定靶点或实验需求提供个性化解决方案。
在技术设备方面，Virogen自主研发的HeartBreaker系列组织匀浆器以高效、低损耗的特性成为样本前处理的重要工具，显著提升实验可重复性。公司凭借多语言技术支持团队（覆盖英语、西班牙语、中文等）构建了全球服务体系，服务网络遍及北美、欧洲、亚洲等多个研究重镇，助力跨国科研协作。
Virogen深耕传染病、癌症生物标志物、神经科学等热点领域，其试剂广泛应用于疫苗开发、疾病机制研究和体外诊断（IVD）产品研发。公司坚持"以科学家服务科学家"的理念，通过优化供应链管理提供高性价比产品，同时推出定期活动（Deal Offerings），降低科研成本门槛。
特别告知：为保证产品质量与良好性能，所以在购买相应产品的同时我司会收取一定量的运输费用！！！本次报价有效时间为2025年6月26日---2025年12月14日。
（*此为部分产品价格,完整价格请下载文件）
货号 | 品名 | 规格 | 价格 | 品牌 |
00211-V-100ug | HHV-4 recombinant p18 antigen Region: 1-119aa | 100ug/vial | 3000.00 | Virogen |
00212-V-100ug | HHV-4 recombinant mosaic EBNA1 antigen. Region: 1-90/408-498aa | 100ug/vial | 3000.00 | Virogen |
00213-V-100ug | HHV-4 recombinant EA antigen. Region: 306-390aa | 100ug/vial | 3000.00 | Virogen |
00167-V-100ug | HDV Ag recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00214-V-100ug | Tick-born encephalitis virus gE recombinant antigen | 100ug/vial | 3000.00 | Virogen |
01005-V-100ug | Chlamydia trachomatis PDP3-D, Full length recombinant | 100ug/vial | 3000.00 | Virogen |
01011-V-100ug | Chlamydia trachomatis MOMP Recombinant antigen with out transmembrane domain. | 100ug/vial | 3000.00 | Virogen |
00206-V-100ug | Toxoplasma gondii MIC 3 recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00207-V-100ug | Toxoplasma gondii P24 (GRA1) recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00208-V-100ug | Toxoplasma gondii P29 (GRA7) recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00209-V-100ug | Toxoplasma gondii P30 (SAG1) recombinant antigen | 100ug/vial | 3000.00 | Virogen |
00111-V-100ug | HIV-1 gag p24 recombinant antigen a.a 77 to a.a 436 of the HIV-1 gag region 39 kDa | 100ug/vial | 3000.00 | Virogen |
00112-V-100ug | HIV-1 nef recombinant antigen a.a 3 to a.a 190 of the HIV-1 nef region 20 kDa | 100ug/vial | 3000.00 | Virogen |
00113-V-100ug | HIV-1 env gp41 recombinant antigen a.a 466 to a.a 753 of the HIV-1 env region 32 kDa | 100ug/vial | 3000.00 | Virogen |
00114-V-100ug | HIV -2 env gp36 recombinant antigen a.a 390 to a.a 702 of the HIV-2 env region 34 kDa | 100ug/vial | 3000.00 | Virogen |
00168-V-100ug | HIV-1 p17/24/gp120-gp41 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00169-V-100ug | HIV-1 p17/24/gp120 antigen.The protein contains the HIV immunodominant regions from gag p17-p24 gp 120. | 100ug/vial | 3000.00 | Virogen |
00170-V-100ug | HIV-1 gp41 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00171-V-100ug | HIV-1 gp41 Long recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00172-V-100ug | HIV-1 p17-p24 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00173-V-100ug | HIV-2 gp32 recombinant antigen. . | 100ug/vial | 3000.00 | Virogen |
00174-V-100ug | HIV-1 p24 recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00175-V-100ug | HIV 1, 2 envelope recombinant antigen. HIV-1 envelope conjugated to HIV-2 envelope peptide. | 100ug/vial | 3000.00 | Virogen |
00176-V-100ug | HIV 1 envelope recombinant antigen. HIV-1 evnelope protein spanning the C-Terminus of gp 120 and most of gp 41. | 100ug/vial | 3000.00 | Virogen |
00177-V-100ug | HIV 1 p24 core recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00178-V-100ug | HIV type O envelope antigen. Synthetic HIV type-O peptide, containing the HIV type-O envelope-derived sequence. | 100ug/vial | 3000.00 | Virogen |
00179-V-100ug | HIV -2 env gp36 recombinant antigen. a.a 390 to a.a 702. | 100ug/vial | 3000.00 | Virogen |
00110-V-100ug | HIV-1 tat recombinant antigen full length 15 kDa | 100ug/vial | 3000.00 | Virogen |
00180-V-100ug | HIV 2 gp36 envelope antigen. Synthetic HIV-2 Peptide containing the HIV-2 specific sequence of gp36. | 100ug/vial | 3000.00 | Virogen |
00198-V-100ug | HIV-1 reverse transcriptase recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00199-V-100ug | HIV-1 intergase antigen. The protein contains the HIV-1 immunodominant regions from pol protein (integrase). | 100ug/vial | 3000.00 | Virogen |
00115-V-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa | 100ug/vial | 3000.00 | Virogen |
00115-V-B-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Biotin conjugate. | 100ug/vial | 3000.00 | Virogen |
00115-V-F-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa. Fluorescein conjugate. | 100ug/vial | 3000.00 | Virogen |
00115-V-R-100ug | HCV core recombinant antigen a.a 2 to a.a 192 of HCV polyprotein 22 kDa . Rhodamine conjugate. | 100ug/vial | 3000.00 | Virogen |
00116-V-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. | 100ug/vial | 3000.00 | Virogen |
00116-V-B-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Biotin conjugate. | 100ug/vial | 3000.00 | Virogen |
00116-V-F-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Fluorescein conjugate. | 100ug/vial | 3000.00 | Virogen |
00116-V-R-100ug | HCV NS4 recombinant antigen NS4a+b a.a 1658 to a.a 1863 of HCV polyprotein, 19 kDa. Rhodamine conjugate. | 100ug/vial | 3000.00 | Virogen |
00117-V-100ug | HCV NS3 recombinant antigen a.a 1400 to a.a 1643 of HCV polyprotein 22 kDa | 100ug/vial | 3000.00 | Virogen |
00150-V-100ug | HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a | 100ug/vial | 3000.00 | Virogen |
00151-V-100ug | HCV core 24 antigen. | 100ug/vial | 3000.00 | Virogen |
00152-V-100ug | HCV core recombinant antigen a.a.105-302 | 100ug/vial | 3000.00 | Virogen |
00153-V-100ug | HCV NS3 1192-1456aa recombinant antigen a.a.1192-1459. Available genotypes: 1a, 1b, 2b, 2c, 5, 6a | 100ug/vial | 3000.00 | Virogen |
00154-V-100ug | HCV NS3 1359-1456aa antigen. The protein contains immunodominant regions (1359-1456aa). available genotypes: 1a, 1b, 2b, 3, 4, 5, 6 | 100ug/vial | 3000.00 | Virogen |
00155-V-100ug | HCV NS4 mosaic recombinant antigen a.a1691-1710, 1712-1733, 1921-1940. Genotypes available: 1, 2, 3, 5. | 100ug/vial | 3000.00 | Virogen |
00156-V-100ug | HCV NS4 1916-1947aa recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00157-V-100ug | HCV NS5 2061-2302aa recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00158-V-100ug | HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a. | 100ug/vial | 3000.00 | Virogen |
00120-V-100ug | HBV core recombinant antigen HBcAg a.a 1 to a.a 183 of HBV core antigen 18 kDa | 100ug/vial | 3000.00 | Virogen |
00121-V-100ug | HBV core recombinant antigen HBcAg a.a 1 to a.a 144 of HBV core antigen 16 kDa | 100ug/vial | 3000.00 | Virogen |
00122-V-100ug | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant | 100ug/vial | 3000.00 | Virogen |
00123-V-100ug | HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity | 100ug/vial | 3000.00 | Virogen |
00124-V-100ug | HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant | 100ug/vial | 3000.00 | Virogen |
00131-V-100ug | HEV (Birma) ORF2 recombinant antigen a.a. 633 to a.a 659. | 100ug/vial | 3000.00 | Virogen |
00132-V-100ug | HEV (Birma) ORF2 recombinant antigen a.a. 403 to a.a 461. | 100ug/vial | 3000.00 | Virogen |
00133-V-100ug | HEV (Birma) ORF2 recombinant antigen a.a. 92 to a.a 123. | 100ug/vial | 3000.00 | Virogen |
00141-V-100ug | T. Pallidum recombinant antigen p15 (full length) | 100ug/vial | 3000.00 | Virogen |
00142-V-100ug | T. Pallidum recombinant antigen p17 (full length) | 100ug/vial | 3000.00 | Virogen |
00143-V-100ug | T. Pallidum recombinant antigen p45 (full length) | 100ug/vial | 3000.00 | Virogen |
00144-V-100ug | T. Pallidum recombinant antigen TmpA (full length) | 100ug/vial | 3000.00 | Virogen |
00185-V-100ug | CMV Pp65 (UL83) recombinant antigen , full length | 100ug/vial | 3000.00 | Virogen |
00188-V-100ug | CMV Pp65 (UL83) recombinant antigen a.a. 297-510 | 100ug/vial | 3000.00 | Virogen |
00189-V-100ug | CMV Pp52 (UL44) recombinant antigen a.a. 271-428 | 100ug/vial | 3000.00 | Virogen |
00187-V-100ug | CMV gB-AD1 (UL55) recombinant antigen a.a. 549-645 | 100ug/vial | 3000.00 | Virogen |
00186-V-100ug | CMV Pp150 recombinant antigen a.a. 426-606 | 100ug/vial | 3000.00 | Virogen |
00159-V-100ug | HAV VP1-P2A recombinant antigen a.a. 722-830. | 100ug/vial | 3000.00 | Virogen |
00160-V-100ug | HAV VP4-VP2 recombinant antigen a.a. 55-164. | 100ug/vial | 3000.00 | Virogen |
00161-V-100ug | HAV P2C-P3A recombinant antigen a.a. 1492-1606. | 100ug/vial | 3000.00 | Virogen |
00162-V-100ug | HAV P3C recombinant antigen a.a. 1643-1743. | 100ug/vial | 3000.00 | Virogen |
00163-V-100ug | HAV VP3 recombinant antigen a.a. 304-415. | 100ug/vial | 3000.00 | Virogen |
00164-V-100ug | HAV VP1-P2A recombinant antigen a.a. 669-782. | 100ug/vial | 3000.00 | Virogen |
00165-V-100ug | HAV HAV P2C recombinant antigen a.a. 1121-1234. | 100ug/vial | 3000.00 | Virogen |
00166-V-100ug | HAV P2C-P3A recombinant antigen a.a. 1392-1521. | 100ug/vial | 3000.00 | Virogen |
00181-V-100ug | HSV-1 gD recombinant antigen a.a. 266-394. | 100ug/vial | 3000.00 | Virogen |
00182-V-100ug | HSV-2 gD recombinant antigen a.a. 266-394. | 100ug/vial | 3000.00 | Virogen |
00183-V-100ug | HSV-2 gD recombinant antigen a.a. 525-578. | 100ug/vial | 3000.00 | Virogen |
00184-V-100ug | HSV-1 gD recombinant antigen a.a. 84-175. | 100ug/vial | 3000.00 | Virogen |
1131-V-100ug | HSV-2 gB recombinant antigen | 100ug/vial | 3000.00 | Virogen |
1140-V-100ug | E. coli recombinant HSV II gG antigen. Immunodominant Region: a.a. 525-578 | 100ug/vial | 3000.00 | Virogen |
00203-V-100ug | HLTV-I envelope recombinant antigen. C-terminus of gp-46 and most of p21. | 100ug/vial | 3000.00 | Virogen |
00204-V-100ug | HLTV-I p24 core recombinant antigen. | 100ug/vial | 3000.00 | Virogen |
00205-V-100ug | HTLV-1 virus mosaic recombinant antigen a.a. 374-400/190-207. | 100ug/vial | 3000.00 | Virogen |
00700-V-100ug | HTLV-1 gp21 recombinant protein | 100ug/vial | 3000.00 | Virogen |
00701-V-100ug | HTLV-1 gp46 recombinant protein | 100ug/vial | 3000.00 | Virogen |
00215-V-100ug | Rubella virus E1 mosaic recombinant antigen a.a. 157-176/374-390/213-239. | 100ug/vial | 3000.00 | Virogen |
00216-V-100ug | Rubella virus E2 recombinant antigen a.a. 31-105. | 100ug/vial | 3000.00 | Virogen |
00217-V-100ug | Rubella virus capsid (C) recombinant antigen a.a. 1-123. | 100ug/vial | 3000.00 | Virogen |
00191-V-100ug | SARS-Associated Coronavirus E recombinant antigen a.a. 1-76. | 100ug/vial | 3000.00 | Virogen |
00192-V-100ug | SARS-Associated Coronavirus Nucleocapsid recombinant antigen N a.a. 1-49. | 100ug/vial | 3000.00 | Virogen |
00193-V-100ug | SARS-Associated Coronavirus Nucleocapsid recombinant antigen C a.a. 340-390. | 100ug/vial | 3000.00 | Virogen |
00194-V-100ug | SARS-Associated Coronavirus M recombinant antigen a.a. 182-216. | 100ug/vial | 3000.00 | Virogen |
00195-V-100ug | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(N) a.a. 12-53/90-115/171-203. | 100ug/vial | 3000.00 | Virogen |
00196-V-100ug | SARS-Associated Coronavirus Spike mosaic recombinant antigen S(M) a.a. 408-470/540-573. | 100ug/vial | 3000.00 | Virogen |
00197-V-100ug | SARS-Associated Coronavirus Spike mosaic recombinant antigen S© a.a. 1051-1076/1121-1154/1162-1190. | 100ug/vial | 3000.00 | Virogen |
00200-V-100ug | VZV gE recombinant antigen a.a. 48-135. | 100ug/vial | 3000.00 | Virogen |
00201-V-100ug | VZV ORF9 recombinant antigen a.a. 6-28/76-100. | 100ug/vial | 3000.00 | Virogen |
00202-V-100ug | VZV ORF26 recombinant antigen a.a. 9-33/184-208. | 100ug/vial | 3000.00 | Virogen |
00401-V-100ug | West Nile Virus Envelope recombinant antigen-Immunodominant region | 100ug/vial | 3000.00 | Virogen |
00402-V-100ug | West Nile Virus Pre-M recombinant antigen-Immunodominant region | 100ug/vial | 3000.00 | Virogen |
00403-V-100ug | West Nile Virus Envelope full length recombinant antigen 42 kDa region | 100ug/vial | 3000.00 | Virogen |
00345-V-100ug | Zika Virus ENV -NS1 fusion antigen 54 kDa | 100ug/vial | 3000.00 | Virogen |
00346-V-100ug | Zika Virus NS1 antigen 34 kDa | 100ug/vial | 3000.00 | Virogen |
00347-V-100ug | H. pylori CogA antigen 34 kDa | 100ug/vial | 3000.00 | Virogen |
00321-V-100ug | Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280 | 100ug/vial | 3000.00 | Virogen |
1170-V-100ug | Human Endogenous Retrovirus Envelope antigen 48 kDa | 100ug/vial | 3000.00 | Virogen |
3001-V-100ug | Prostatic pacid hosphatase - full length (human) | 100ug/vial | 3000.00 | Virogen |
3002-V-100ug | Ovine Prolactin | 100ug/vial | 3000.00 | Virogen |
00820-V-100ug | MPXV A29 (recombinant), partial., a.a. 1-110. pI/Mw: 6.44 / 13382.09 | 100ug/vial | 3000.00 | Virogen |
00821-V-100ug | MPXV A27 (recombinant), partial., a.a. 1-110. MW: ~14 kDa | 100ug/vial | 3000.00 | Virogen |
00900-V-100ug | Phospholipase A2 P00630 Bee Venom Recombinant Protein | 100ug/vial | 3000.00 | Virogen |
00901-V-100ug | Soy Bean p34 Recombinant protein | 100ug/vial | 3000.00 | Virogen |
900-V-100ug | Dermatophagoides farina Der F1 antigen (recombinant). Full length. Non enzymatically active. | 100ug/vial | 3000.00 | Virogen |
901-V-100ug | Dermatophagoides pteronyssinus Der P1 antigen . Full length. Non enzymatically active. | 100ug/vial | 3000.00 | Virogen |
012-A-100ug | anti-HIV-1 p24 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
013-A-100ug | anti-HIV-1 p55/17 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
014-A-100ug | anti-HIV-1 p17 IgG1 (monoclonal) Produced against a recombinant protein | 100ug/vial | 3000.00 | Virogen |
0114-A-100ug | anti-HIV-2 gp36 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
015-A-100ug | anti-HIV-1 gp41 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
016-A-100ug | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
017-A-100ug | anti-HCV core IgG2a (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
018-A-100ug | anti-HCV NS4 IgG2a (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
020-A-100ug | anti-HSV (I) gD IgG1 (monoclonal) Produced against a HSV (I) viral concentrate | 100ug/vial | 3000.00 | Virogen |
021-A-100ug | anti-HSV (II) gB IgG1 (monoclonal) Produced against a HSV (II) infected cells. | 100ug/vial | 3000.00 | Virogen |
022-A-100ug | anti-HCMV IE pp72 IgG2a (monoclonal) Produced against a HCMV IE concentrate. | 100ug/vial | 3000.00 | Virogen |
023-A-100ug | anti-HCMV IE pp65 IgG1 (monoclonal) Produced against a HCMV infected cells. | 100ug/vial | 3000.00 | Virogen |
024-A-100ug | anti-HCMV gB IgG1 (monoclonal) Produced against a HCMV infected cells. | 100ug/vial | 3000.00 | Virogen |
025-A-100ug | anti-Adenovirus E11 IgG2a (monoclonal) Produced against purified Ad1 virus | 100ug/vial | 3000.00 | Virogen |
026-A-100ug | anti-Adenovirus C11 IgG2a (monoclonal) Produced against purified Ad7 virus | 100ug/vial | 3000.00 | Virogen |
027-A-100ug | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 100ug/vial | 3000.00 | Virogen |
028-A-100ug | anti-TGE IgG1 (monoclonal) Produced against purified TGE virus 1E11. | 100ug/vial | 3000.00 | Virogen |
030-A-100ug | anti-HBcAg core IgM (monoclonal) Produced against recombinant HBcAg core antigen. | 100ug/vial | 3000.00 | Virogen |
031-A-100ug | anti-HBsAg pre-surface IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 100ug/vial | 3000.00 | Virogen |
032-A-100ug | anti-HBsAg surface antigen IgG1 (monoclonal) Produced against HBsAg purified from human sera pool. | 100ug/vial | 3000.00 | Virogen |
033-A-100ug | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 70 – 80 a.a. | 100ug/vial | 3000.00 | Virogen |
034-A-100ug | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 135-140 a.a. | 100ug/vial | 3000.00 | Virogen |
035-A-100ug | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope:141-154 a.a. | 100ug/vial | 3000.00 | Virogen |
036-A-100ug | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 1-10 a.a. | 100ug/vial | 3000.00 | Virogen |
037-A-100ug | anti-HBcAg core IgG2b (monoclonal) Produced against recombinant HBcAg core antigen (ayw). Epitope: 138- 145 a.a. | 100ug/vial | 3000.00 | Virogen |
038-A-100ug | anti-HBcAg core IgG2a (monoclonal) Produced against recombinant HBcAg core antigen. Epitope: 130-140 a.a. | 100ug/vial | 3000.00 | Virogen |
0116-A-100ug | anti-HCV core IgG1 (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 100ug/vial | 3000.00 | Virogen |
0117-A-100ug | anti-HCV core IgG2a (monoclonal) Produced against a recombinant, HCV core 00115-V, protein. | 100ug/vial | 3000.00 | Virogen |
216-A-100ug | anti-HCV core IgG1 (monoclonal)Produced against recombinant antigen | 100ug/vial | 3000.00 | Virogen |
245-A-100ug | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a. 1748 to 1754 | 100ug/vial | 3000.00 | Virogen |
246-A-100ug | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen | 100ug/vial | 3000.00 | Virogen |
247-A-100ug | anti-HCV NS4B IgG2b (monoclonal)Produced against recombinant antigen epitope a.a 1713 to 1717 | 100ug/vial | 3000.00 | Virogen |
266-A-100ug | anti-HCV NS5b rabbit (polycnonal)Produced against a recombinant protein | 100ug/vial | 3000.00 | Virogen |
199-A-100ug | anti-HCV NS5a rabbit (polycnonal) Produced against a recombinant protein | 100ug/vial | 3000.00 | Virogen |
276-A-100ug | anti-Rotavirus p42 IgG2a (monoclonal) Produced against purified bovine rotavirus virus. | 100ug/vial | 3000.00 | Virogen |
010-A-100ug | anti-Rabies G antigen monoclonal antibody. Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
111-A-100ug | anti-Dengue NS1 Type 2 IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
101-A-100ug | anti-Glutathione monoclonal antibody IgG1 | 100ug/vial | 3000.00 | Virogen |
102-A-100ug | anti-Cysteine monoclonal antibody IgG1 | 100ug/vial | 3000.00 | Virogen |
105-A-100ug | anti-Ergothioneine rabbit polyclonal antibody | 100ug/vial | 3000.00 | Virogen |
041-A-100ug | anti-Thyroxine monoclonal antibody IgG2a | 100ug/vial | 3000.00 | Virogen |
011-A-100ug | anti-GSK3 Beta IgG2a (monoclonal). Produced against a recombinant Xenopus laevis protein. | 100ug/vial | 3000.00 | Virogen |
019-A-100ug | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
029-A-100ug | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
039-A-100ug | anti-FAS IgG1 (monoclonal) Produced against a recombinant protein. | 100ug/vial | 3000.00 | Virogen |
049-A-100ug | anti-FAS IgM (monoclonal) | 100ug/vial | 3000.00 | Virogen |
059-A-100ug | anti-SLAM anti-CDw150 IgG2a (monoclonal) Produced against an activated B cell line. | 100ug/vial | 3000.00 | Virogen |
069-A-100ug | anti-CD37 IgG2b (monoclonal) Produced against a B cell line. | 100ug/vial | 3000.00 | Virogen |
079-A-100ug | anti-Nuclear Antigen (Proliferating Cells) IgM (monoclonal) Produced against a proliferating Harvey cell line. | 100ug/vial | 3000.00 | Virogen |
066-A-100ug | anti-p53, clone BP53-12 | 100ug/vial | 3000.00 | Virogen |
060-A-100ug | anti-CD3 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
061-A-100ug | anti-CD4 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
062-A-100ug | anti-CD8 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
063-A-100ug | anti-CD16 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
064-A-100ug | anti-CD20 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
065-A-100ug | anti-CD22 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
067-A-100ug | anti-CD45 RA IgG2 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
068-A-100ug | anti-CD54 IgG2b-k monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
071-A-100ug | anti-CD19 IgG1 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
089-A-100ug | anti-CD66e IgG1 monoclonal antibody | 100ug/vial | 3000.00 | Virogen |
501-A-100ug | anti-CD3 T-cell | 100ug/vial | 3000.00 | Virogen |
502-A-100ug | anti-CD4 T helper cells | 100ug/vial | 3000.00 | Virogen |
503-A-100ug | anti-CD5 All T-cells | 100ug/vial | 3000.00 | Virogen |
504-A -100ug | anti-CD7 All T-cells | 100ug/vial | 3000.00 | Virogen |
505-A -100ug | anti-CD8 T cytotoxic/supressor cells | 100ug/vial | 3000.00 | Virogen |
506-A -100ug | anti-CD10 Lymphoblasts | 100ug/vial | 3000.00 | Virogen |
507-A -100ug | anti-CD16 NK-cells, monocytes, granulocytes | 100ug/vial | 3000.00 | Virogen |
508-A -100ug | anti-CD18 Leucocytes | 100ug/vial | 3000.00 | Virogen |
509-A-100ug | anti-CD20 B-lymphocytes | 100ug/vial | 3000.00 | Virogen |
510-A-100ug | anti-CD22 B-lymphocytes | 100ug/vial | 3000.00 | Virogen |
511-A-100ug | anti-CD25 IL-2 receptor expressed on activated T and B cells | 100ug/vial | 3000.00 | Virogen |
512-A-100ug | anti-CD26 Activated T, B lymphocytes and macrophages | 100ug/vial | 3000.00 | Virogen |
513-A-100ug | anti-CD34 Hematopoietic precursor cells | 100ug/vial | 3000.00 | Virogen |
514-A-100ug | anti-CD38 Hematopoietic precursors, thymocytes, activated T-cells, plasma cells | 100ug/vial | 3000.00 | Virogen |
515-A-100ug | anti-CD45 Leukocytes | 100ug/vial | 3000.00 | Virogen |
516-A-100ug | anti-CD45 RA B-cells, T-cells, NK-cells | 100ug/vial | 3000.00 | Virogen |
517-A-100ug | anti-ICAM-3, Leukocytes | 100ug/vial | 3000.00 | Virogen |
518-A-100ug | anti-Transferrin receptor on activated T-B-, cells | 100ug/vial | 3000.00 | Virogen |
519-A-100ug | anti-FAS antigen | 100ug/vial | 3000.00 | Virogen |
520-A-100ug | anti-HLA-DR | 100ug/vial | 3000.00 | Virogen |
521-A-100ug | anti-HLA-ABC on all Leukocytes | 100ug/vial | 3000.00 | Virogen |
522-A-100ug | anti-IgM Heavy chain expressed on B cells | 100ug/vial | 3000.00 | Virogen |
523-A-100ug | anti-Cortical thymocytes | 100ug/vial | 3000.00 | Virogen |
131-A-100ug | anti-RhoD human antigen IgG1 | 100ug/vial | 3000.00 | Virogen |
132-A-100ug | anti-A1, A2 human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
133-A-100ug | anti-A1, A2, A3 human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
134-A-100ug | anti-B human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
135-A-100ug | anti-AB human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
136-A-100ug | anti-Rh(o)D human antigen IgM | 100ug/vial | 3000.00 | Virogen |
137-A-100ug | anti-Rh(o)D and Rh(o)Dii human Rhesus system antigen IgG1 | 100ug/vial | 3000.00 | Virogen |
138-A-100ug | anti-RhoC human Rhesus system antigen IgM | 100ug/vial | 3000.00 | Virogen |
139-A-100ug | anti-A1, A2 human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
140-A-100ug | anti-B human blood group antigen IgM | 100ug/vial | 3000.00 | Virogen |
141-A-100ug | anti-H n/ab human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
142-A-100ug | anti-H ab human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
143-A-100ug | anti-H inh human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
144-A-100ug | anti-M human blood antigen IgM | 100ug/vial | 3000.00 | Virogen |
145-A-100ug | anti-N human blood antigen Ig2b | 100ug/vial | 3000.00 | Virogen |
146-A-100ug | Antiglobulin (COOMBS) Rabbit polyclonal | 100ug/vial | 3000.00 | Virogen |
109-E | E. coli extract | 100ug/vial | 3000.00 | Virogen |
免责声明
- 凡本网注明“来源：Ky开元集团”的所有作品，均为浙江兴旺宝明通网络有限公司-Ky开元集团合法拥有版权或有权使用的作品，未经本网授权不得转载、摘编或利用其他方式使用上述作品。已经本网授权使用作品的，应在授权范围内使用，并注明“来源：Ky开元集团”。违反上述声明者，本网将追究其相关法律责任。
- 本网转载并注明自其他来源（非Ky开元集团）的作品，目的在于传递更多信息，并不代表本网赞同其观点和对其真实性负责，不承担此类作品侵权行为的直接责任及连带责任。其他媒体、网站或个人从本网转载时，必须保留本网注明的作品第一来源，并自负版权等法律责任。
- 如涉及作品内容、版权等问题，请在作品发表之日起一周内与本网联系，否则视为放弃相关权利。
采购中心
